Showing results (521-530 of 1,241) with videos related to
Sort By:
Pageof 125
Cardiovascular Research|July 1, 1975
Ventricular fibrillation threshold in acute myocardial infarction and its relation to myocardial infarct sizeC M Bloor, A Ehsani, F C White, et al.Journal of Cardiovascular Pharmacology|May 12, 2011
The angiotensin receptor blocker, azilsartan medoxomil (TAK-491), suppresses vascular wall expression of plasminogen activator inhibitor type-I protein potentially facilitating the stabilization of atherosclerotic plaquesChristopher J French, A K M Tarikuz Zaman, Burton E SobelThe American Journal of Cardiology|April 1, 1976
Improved detection of myocardial infarction with technetium-99m stannous pyrophosphate and serum MB creatine phosphokinaseR E Coleman, M S Klein, R Roberts, et al.Journal of the American College of Cardiology|April 1, 1992
"Plasminogen steal" and clot lysisS R Torr, D A Nachowiak, S Fujii, et al.The Journal of Experimental Medicine|October 30, 2009
SURVIVAL OF THE VIRUS OF POLIOMYELITIS IN THE ORAL AND NASAL SECRETION OF CONVALESCENTSS D Kramer, A E Sobel, L H Grossman, et al.Biochemical and Biophysical Research Communications|February 28, 1991
The high affinity murine laminin receptor is a member of a multicopy gene familyM T Fernández, V Castronovo, C N Rao, et al.The American Journal of Cardiology|April 1, 1977
Effects of dobutamine in patients with acute myocardial infarctionT A Gillespie, H D Ambos, B E Sobel, et al.The American Journal of Cardiology|May 1, 1981
Detection of cardiomyopathic changes induced by doxorubicin based on quantitative analysis of ultrasonic backscatterJ W Mimbs, M O'Donnell, J G Miller, et al.The Medical Clinics of North America|January 1, 1988
Thrombolytic therapy in acute myocardial infarction: Part IH S Mueller, R Roberts, S L Teichman, et al.The Medical Clinics of North America|March 1, 1989
Thrombolytic therapy in acute myocardial infarction: Part II--rt-PAH S Mueller, R Roberts, S L Teichman, et al.Pageof 125